Three alumni from Cohort 2 of the MedTech Venture Builder have recently secured significant funding to help drive their ventures forward.
BeCertain has raised £1.7 million in pre-seed funding to accelerate their mission to bring trustworthy, clinical-grade AI to dental diagnostics. The investment round was led by SVV (Sure Valley Ventures) and supported by Innovate UK’s Investor Partnership Growth Catalyst programme.
Impli has been selected for the SPRIND - Bundesagentur für Sprunginnovationen Continuous Hormone Monitoring Challenge, with up to €6 million in non-dilutive funding over three years. The programme will help drive Impli’s continuous hormone monitoring platform to its next stage in polyendocrine metabolic ovarian syndrome (PMOS), where continuous data streams could resolve some of the toughest challenges in hormone health.
EarSwitch has secured investment from South East Angels. EarSwitch are transforming how we monitor and diagnose health through in-ear innovations.
Congratulations to all our alumni ventures!
We recently celebrated Cohort 2 completing 12 months on the MedTech Venture Builder programme. Founders pitched to a room of innovators, industry leaders and investors, showcasing ventures tackling real-world challenges across women’s health, cancer, dentistry, wound care and imaging.
The day also brought together previous cohorts from our MedTech programmes, with 23 demos across all floors of LIHE – a brilliant snapshot of the innovation happening here, from early-stage concepts to investment-ready technologies moving towards clinical adoption.
We kicked off Cohort 3 of the MedTech Venture Builder with a two-day bootcamp, including lightning pitches from the 11 ventures, roundtables with our experts and a session on venture benchmarking delivered by Sam Dods and Uday Phadke from Triple Chasm.
The bootcamp ended with LIHE Venture Demo Day, where Cohort 3 got to see first-hand the progress made by Cohort 2 and other ventures that have taken part in LIHE programmes, offering a glimpse of where their own journey could lead.
Over the next 12 months, the ventures will work with our experts to de-risk and accelerate the commercial readiness of their medical devices.
Earlier this month, we welcomed our third cohort of King’s MedTech Accelerator innovators from across King’s College London, King’s Health Partners, NIHR HealthTech Research Centre in Brain Health and The Royal College of Surgeons of England, all set to turn their research into real-world healthcare impact.
Cohort 3 completed a three-day bootcamp at LIHE, including workshops, a panel discussion and talks from founders. Over the next six months, they will take part in masterclasses covering health technology assessment, regulations and pitching, to name a few.
LIHE is partnering with the Japan External Trade Organization (JETRO), with the support of the Ministry of Economy, Trade and Industry (METI), to launch a new programme called the J-StarX UK HealthTech Launchpad.
The programme supports Japan-based MedTech and digital health startups as they expand into the UK and European markets. To mark the start of Phase 1, members of the LIHE team travelled to Tokyo for the programme’s bootcamp, where they held expert roundtables and strategic planning sessions, helping each startup define its priorities for UK market entry.
This month we were proud to welcome Liz Kendall MP, the then Secretary of State for Science, Innovation and Technology, to LIHE to announce a new charter to support women in research.
During the visit, Research Translation & Innovation Manager Antoinette Cameron-Pimblett and Head of Clinical Translation & Governance Valentina Vitiello led a tour of the building, showcasing our facilities and the ecosystem in which clinicians, engineers and entrepreneurs work together to translate research into clinical impact.
The Secretary of State was also given a demonstration of Fraiya Ultrasound, a King’s spinout based at LIHE with an AI tool for fetal anomaly scans.
At LIHE, we are dedicated to helping bring MedTech innovations to life with real benefits to clinicians and patients. We are already home to corporate partners such as Siemens Healthineers and NVIDIA, and startups and spinouts such Fraiya, Hypervision Surgical and XRLabs, and now we are opening our doors even wider with our membership packages.
The packages give members flexible access to our facilities and MedTech ecosystem, including hotdesking, room booking and events. Whether you need a touchdown space for an afternoon, a few days a week or full-time access, you’ll be working alongside others navigating the MedTech landscape.
Find out more by contacting lihe.ops@kcl.ac.uk
King’s College London has announced a new founder-friendly equity framework for university spinouts, increasing the ownership stake retained by academic founders at formation to between 85% and 100%. The university’s share will now vary according to the type of intellectual property underpinning the venture, aligning with sector best practice. The change aims to attract entrepreneurial talent, increase investor confidence and help innovations reach patients and communities faster.
Healthcare delivery belongs in hospitals and community practices. But healthtech innovation happens in a messy interplay between academic institutions, NHS trusts, tech transfer offices, funding bodies, accelerators, VC funds and the people who decide what actually gets adopted. The pathway is confusing – and for most clinicians, invisible. So brilliant ideas stall.
Join LIHE and the Royal College of Surgeons of England’s Innovation Hub for a day that follows healthtech innovation through its whole life – from first spark to NHS adoption – putting one question on trial at every stage: whose job is it to carry it forward?
Tuesday 15 September, 10am-4pm at the Royal College of Surgeons of England.
No posts
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.